Biografia
Chris Spooner was appointed CEO of Sinclair Pharma in December 2009. He has 15 years’ experience in analysing and investing in life science companies, having been a top-rated pharmaceuticals analyst at various investment banks, including JP Morgan, Deutsche Bank, Donaldson Lufkin & Jenrette and Bank of America. Prior to joining Sinclair he was the founding partner and CEO of HealthCor Management UK LLP, the European division of HealthCor LP, a leading New York based specialist healthcare fund. He holds an MA in Economics from King’s College, Cambridge.
